A recent report published by Infinium
Global Research on the bacteriophage market provides an in-depth analysis of segments
and sub-segments in the global as well as regional bacteriophage market. The
study also highlights the impact of drivers, restraints, and macro indicators
on the global and regional bacteriophage market over the short term as well as
long term. The report is a comprehensive presentation of trends, forecast and
dollar values of the global bacteriophage market. According to the report, the
global bacteriophage market is projected to grow at a CAGR of 4.3% over the
forecast period of 2020-2026.
A bacteriophage is a virus that infects
and replicates within archaea and bacteria. These are composed of a nucleic
acid molecule surrounded by a protein structure. It attracts itself to a
susceptible bacterium and infects the host cell. It prevents it from producing
bacterial components. Bacteriophages can infect and kill bacteria without any
negative effect on animal or human cells. Bacteriophages are anticipated as the
most widely distributed and varied entities in the biosphere. Nowadays, their
potential to be utilized as phage display systems, antibacterial, vehicles for
vaccines and biocontrol agents, and the attention towards bacteriophage is
rekindled.
Additionally, the current concern over
the spread of coronavirus is also expected to have a negative impact on the
bacteriophage market. The enforced quarantine in China, India, and many other
countries has hit the supply-chain hardest as these countries have transitioned
from being a key player in the bacteriophage market. Governments globally
implemented quarantine and travel limitations to curb the spread of the
COVID-19 pandemic; however, such measures threaten industrial operation.
Together with temporary shutdowns in some countries, the bacteriophage industry
also faces severe consequences of supply chain disruptions.
Bacteriophages are an efficient tool
used in modern biotechnology through several types of research to advocate the
potential usage of bacteriophages in various applications. The rising use of
biocontrol agents in the petroleum and agriculture industry will augment the
growth of the bacteriophage market. The increasing research and development
funding for investigating bacteriophage therapy in clinical applications boosts
the growth of the bacteriophage market. Further, bacteriophages are used as
vaccine vehicles for detecting pathogenic bacterial strain complement market
growth. The growing demand for bacteriophages as display systems in various
antibodies and proteins stimulate the development of the bacteriophage market.
In addition, bacteriophages are a diverse group of viruses that can be
manipulated and thus have applications in research, therapeutics, and
biotechnology. Furthermore, the increasing adoption of bacteriophages in food
biopreservation, corrosion control, biofilm control, bacterial biosensing
services, and phage-display based selection of biological affinity led to the
growth of the market. On the flip side, the high cost for therapy of
bacteriophage therapy hinders the growth of the bacteriophage market. Moreover,
increasing research for the establishment of bacteriophage as an effective
vaccine delivery system creates growth opportunities for the bacteriophage
market.
Geographically, the global
bacteriophage market is divided into North America, Asia-Pacific, Europe, and
the Rest of the World. North America is expected to have the largest share in
the global bacteriophage market. The well-established research infrastructure,
strong desire to overcome the burden of antibiotic-resistant infections, and the
existence of a potential pipeline for phase therapy in North America contribute
to the growth of the bacteriophage market in North America. Europe is
anticipated to grow with a healthy CAGR in the global bacteriophage market over
the forecast period. The rising application of bacteriophage in food and
environmental field in Europe drive the expansion of bacteriophage market in
the region. Asia-Pacific region has the fastest growth rate in the global
bacteriophage market owing to the rapid evolution of biotechnology
infrastructure and rising supportive initiatives from the government in the
region.
The report on the global bacteriophage
market covers segments such as type, and application. On the basis of type, the
sub-markets include dsDNA Bacteriophage, ssDNA Bacteriophage, and ssRNA bacteriophage.
On the basis of application, the sub-markets include clinical application,
phage display, environmental application, veterinary, and phage therapy.
The report provides profiles of the
companies in the market such as Phage Biotech Ltd., Fixed-Phage Limited,
InnoPhage Ltd., EnBiotix Inc., Pherecydes Pharma SA, TechnoPhage SA, Versatile
Bio Fuels Pvt. Ltd., Federal State Scientific Industrial Company MICROGEN,
Intralytix, Inc., and AmpliPhi Biosciences Corporation.
The report provides deep insights into
the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the bacteriophage market. Moreover, the study highlights current market
trends and provides forecast from 2020-2026. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.
Please Choose One of them.